Health · 5 views
Two Biologics for Psoriatic Arthritis Square Off in Big Trial
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 5 Community interest
Brief read Under 1 min brief 32 words
Summary
(MedPage Today) -- ORLANDO -- A large head-to-head trial reported here that pitted bimekizumab (Bimzelx) against risankizumab (Skyrizi) as treatment for psoriatic arthritis (PsA) yielded a winner, albeit with a couple caveats.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Sore throats help inform Strep A vaccine trialsContinue reading
- Even substitute PFAS cause metabolic stress in zebrafish embryosContinue reading
- Consultant doctors in England call off two-day pay strikeContinue reading
- 5,387 Dead in Outbreak; Cheese Recall Expands; Breast Cancer Chemo May Speed AgingContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow